BPMC News and Press, Blueprint Medicines Corporation From 02/15/24

2024-02-15 07:10:28 ET More on Blueprint Medicines Blueprint Medicines: Looking Toppy Blueprint Medicines Q4 2023 Earnings Preview Barron’s cites cancer and weight loss plays for biotech M&A Seeking Alpha’s Quant Rating on Blueprint Medicine...

Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results PR Newswire -- Achieved $204.2 million in AYVAKIT ® /AYVAKYT ® (avapritinib) net product revenues in 2023, including $71.0 million in the fourth quarter -- -- Anti...

Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...

2024-02-14 15:30:47 ET Summary Cogent Biosciences, Inc. has entered into a securities purchase agreement for a private investment in public equity financing, expected to raise approximately $225 million. The financing was led by Commodore Capital and a large investment management ...

2024-02-14 14:07:39 ET More on Blueprint Medicines Blueprint Medicines: Looking Toppy Barron’s cites cancer and weight loss plays for biotech M&A Seeking Alpha’s Quant Rating on Blueprint Medicines Historical earnings data for Blueprint Medi...

2024-02-13 10:15:02 ET Wells Fargo analyst issues MARKET OUTPERFORM recommendation for BPMC on February 13, 2024 10:00AM ET. The previous analyst recommendation was Market Outperform. BPMC was trading at $74.52 at issue of the analyst recommendation. The overall analyst ...

2024-02-04 17:16:46 ET More on Alnylam Pharmaceuticals, Fusion Pharmaceuticals, etc. Merus Stock: Rally Seems Overdone Alnylam's Huge Opportunity Merus: (Maybe) Building A Better Bispecific Regeneron eyes Wegovy combo to improve quality of weight loss ...

Blueprint Medicines to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024 PR Newswire CAMBRIDGE, Mass. , Feb. 1, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live co...

2024-01-28 06:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-17 07:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...